NPR logo

Pfizer: Study Links Celebrex to Heart Problems

  • Download
  • <iframe src="https://www.npr.org/player/embed/4233274/4233275" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Pfizer: Study Links Celebrex to Heart Problems

Health Care

Pfizer: Study Links Celebrex to Heart Problems

Pfizer: Study Links Celebrex to Heart Problems

  • Download
  • <iframe src="https://www.npr.org/player/embed/4233274/4233275" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Pfizer says a study found an increased risk of heart problems with the painkiller Celebrex. The news comes after another painkiller, Vioxx, was withdrawn from the market. Like Vioxx, Celebrex is in a class of drugs called COX-2 inhibitors. Pfizer does not plan to pull Celebrex from the market. Hear NPR's Steve Inskeep and NPR's Richard Knox.

We no longer support commenting on NPR.org stories, but you can find us every day on Facebook, Twitter, email, and many other platforms. Learn more or contact us.